Estudios originales
Published on 10 de abril de 2025 | http://doi.org/10.5867/medwave.2025.03.3033
Retrospective study on disparities in time-to-treatment by health insurance system in Chilean breast cancer patients
Back to article
Multiple linear regression analysis on breast cancer treatment duration by health insurance type and pathological stage.
| Intercept | 9.28 | 5.00 to 13.55 | < 0.0001 |
| Private insurance (ISAPRE) | Ref. | -- | - |
| Public insurance (FONASA) | 15.43 | 10.97 to 19.90 | < 0.0001 |
| Stage I | Ref. | -- | - |
| Stage II | 4.71 | 1.61 to 7.81 | 0.0029 |
| Stage III | 27.44 | 22.82 to 32.06 | < 0.0001 |
Ref., reference. CI, confidence interval.
Adjustment variables were type of health insurance (private or public) and stage at diagnosis (I, II, or III). Total duration of treatment (weeks) was the dependent variable. Coefficients represent the mean difference compared with the reference category. *Confidence intervals were calculated by standard error.
Source: Prepared by the authors.